Protagonist Therapeutics Inc (PTGX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 275,188 | -78,955 | -127,393 | -125,551 | -66,150 |
| Depreciation Amortization | -5,980 | -1,257 | 2,820 | 4,605 | 2,760 |
| Income taxes - deferred | N/A | N/A | N/A | N/A | 1,438 |
| Accounts receivable | -155,000 | -9,990 | 1,556 | 860 | 4,329 |
| Accounts payable and accrued liabilities | 839 | -2,934 | 1,215 | -3,223 | 1,780 |
| Other Working Capital | -122,610 | -19,511 | -7,766 | -3,314 | -19,016 |
| Other Operating Activity | 191,715 | 42,411 | 21,431 | 18,758 | 2,375 |
| Operating Cash Flow | $184,152 | $-70,236 | $-108,137 | $-107,865 | $-72,484 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -1,355 | -609 | -795 | -1,101 | -471 |
| Purchase Of Investment | -621,702 | -191,045 | -214,874 | -286,589 | -280,027 |
| Sale Of Investment | 323,574 | 152,396 | 307,137 | 271,830 | 189,533 |
| Investing Cash Flow | $-299,483 | $-39,258 | $91,468 | $-15,860 | $-90,965 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | N/A | -14 |
| Debt Repayment | N/A | N/A | N/A | N/A | -10,524 |
| Common Stock Issued | 26,453 | 171,246 | 19,001 | 130,112 | 258,164 |
| Other Financing Activity | -600 | -769 | -163 | -189 | 0 |
| Financing Cash Flow | $25,853 | $170,477 | $18,838 | $129,923 | $247,626 |
| Exchange Rate Effect | N/A | N/A | -90 | -126 | 175 |
| Beginning Cash Position | 186,952 | 125,969 | 123,890 | 117,818 | 33,466 |
| End Cash Position | 97,474 | 186,952 | 125,969 | 123,890 | 117,818 |
| Net Cash Flow | $-89,478 | $60,983 | $2,079 | $6,072 | $84,352 |
| Free Cash Flow | |||||
| Operating Cash Flow | 184,152 | -70,236 | -108,137 | -107,865 | -72,484 |
| Capital Expenditure | -1,355 | -609 | -795 | -1,101 | -471 |
| Free Cash Flow | 182,797 | -70,845 | -108,932 | -108,966 | -72,955 |